{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:00:54Z","timestamp":1790103654191,"version":"4.0.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,18]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>DNA methylation is an emerging biomarker for cervical cancer screening. This study aimed to evaluate the diagnostic performance of paired box gene 1\/junctional adhesion molecule 3 (JAM3) dual-gene methylation analysis for detecting high-grade cervical intraepithelial neoplasia and cervical cancer, and to explore its potential utility as a triage biomarker for high-risk human papillomavirus positive women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A systematic search was conducted across 5 databases, including PubMed, for studies on PAX1\/JAM3 methylation testing in cervical cancer screening. Following quality assessment via the QUADAS-2 tool, statistical analyses were performed using Meta-Disc 1.4 and Stata 17 software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Eight studies involving 7494 participants were included in the meta-analysis. For diagnosing cervical intraepithelial neoplasia grade 2 and above the pooled sensitivity was 0.81 (95% CI: 0.73\u20130.88), specificity was 0.95 (95% CI: 0.94\u20130.96), and the area under the curve was 0.96. For diagnosing cervical intraepithelial neoplasia grade 3 and above the pooled sensitivity was 0.85 (95% CI: 0.75\u20130.92), specificity was 0.88 (95% CI: 0.86\u20130.89), and the area under the curve was 0.90.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>PAX1\/JAM3 dual-gene methylation testing demonstrates high diagnostic accuracy for detecting high-grade cervical intraepithelial neoplasia and cervical cancer, supporting its potential role as a triage biomarker in high-risk human papillomavirus positive women.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050757","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:01:54Z","timestamp":1789750914000},"page":"e50757","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Meta-analysis of PAX1\/JAM3 methylation performance in high-risk HPV-positive women"],"prefix":"10.1097","volume":"105","author":[{"given":"Lianxing","family":"Qi","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Shaoxing Shangyu Maternal and Child Health Hospital, Shaoxing, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinfang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Shaoxing Shangyu Maternal and Child Health Hospital, Shaoxing, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5285-4155","authenticated-orcid":false,"given":"Minxia","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Shaoxing Shangyu Maternal and Child Health Hospital, Shaoxing, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260922","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R3-20260922","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors.","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"R4-20260922","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1586\/14737140.2014.856273","article-title":"The current position and the future perspectives of cervical cancer screening.","volume":"14","author":"Bosgraaf","year":"2014","journal-title":"Expert Rev Anticancer Ther"},{"key":"R5-20260922","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/14789450.2021.1980387","article-title":"Molecular markers for cervical cancer screening.","volume":"18","author":"G\u00fczel","year":"2021","journal-title":"Expert Rev Proteomics"},{"key":"R6-20260922","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s40944-021-00529-5","article-title":"Biomarkers for detection of human papillomavirus (HPV).","volume":"19","author":"Kolte","year":"2021","journal-title":"Indian J Gynecol Oncol"},{"key":"R7-20260922","first-page":"376","article-title":"Cancer epigenetics in clinical practice.","volume":"73","author":"Davalos","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"R8-20260922","first-page":"419","article-title":"Feasibility evaluation of using PAX1\/JAM3 methylation markers as cervical cancer screening for female self\u2011collected samples.","volume":"47","author":"Yu","year":"2024","journal-title":"Chin J Lab Med"},{"key":"R9-20260922","first-page":"1820","article-title":"High-grade cervical lesions diagnosed by JAM3\/PAX1 methylation in high-risk human papillomavirus-infected patients.","volume":"48","author":"Li","year":"2023","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"R10-20260922","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1186\/s12885-024-13299-y","article-title":"The performance of JAM3\/PAX1 methylation in the diagnosis of high-grade squamous intraepithelial lesions for women with high-risk HPV infection.","volume":"24","author":"Sun","year":"2024","journal-title":"BMC Cancer"},{"key":"R11-20260922","doi-asserted-by":"crossref","first-page":"1481626","DOI":"10.3389\/fonc.2024.1481626","article-title":"Assessment of PAX1 and JAM3 methylation triage efficacy across HPV genotypes and age groups in high-risk HPV-positive women in China.","volume":"14","author":"Liang","year":"2024","journal-title":"Front Oncol"},{"key":"R12-20260922","doi-asserted-by":"crossref","first-page":"oyae324","DOI":"10.1093\/oncolo\/oyae324","article-title":"Triage performance of DNA methylation for women with high-risk human papillomavirus infection.","volume":"30","author":"Kong","year":"2025","journal-title":"Oncologist"},{"key":"R13-20260922","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1186\/s12885-024-13082-z","article-title":"Cervical cancer screening: efficacy of PAX1 and JAM3 methylation assay in the triage of atypical squamous cell of undetermined significance (ASC-US).","volume":"24","author":"Chen","year":"2024","journal-title":"BMC Cancer"},{"key":"R14-20260922","first-page":"1852","article-title":"A multicenter study on the accuracy of PAX1\/JAM3 dual genes methylation testing for screening cervical cancer.","volume":"104","author":"Shang","year":"2024","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"R15-20260922","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/s41416-025-03005-5","article-title":"The triage role of cytological DNA methylation in women with non-16\/18, specifically genotyping high-risk HPV infection.","volume":"132","author":"Su","year":"2025","journal-title":"Br J Cancer"},{"key":"R16-20260922","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13148-024-01731-w","article-title":"Triage performance of PAX1(m)\/JAM3(m) in opportunistic cervical cancer screening of non\u201216\/18 human papillomavirus-positive women: a multicenter prospective study in China.","volume":"16","author":"Chen","year":"2024","journal-title":"Clin Epigenetics"},{"key":"R17-20260922","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13148-024-01804-w","article-title":"Evaluating PAX1\/JAM3 methylation for triage in HPV 16\/18-infected women.","volume":"16","author":"Fei","year":"2024","journal-title":"Clin Epigenetics"},{"key":"R18-20260922","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/ijgo.70167","article-title":"Cytologic DNA methylation for managing minimally abnormal cervical cancer screening results.","volume":"171","author":"Shang","year":"2025","journal-title":"Int J Gynaecol Obstet"},{"key":"R19-20260922","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.","volume":"100","author":"Rodr\u00edguez","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R20-20260922","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-3-031-11454-0_13","article-title":"The role of DNA methylation and DNA methyltransferases in cancer.","volume":"1389","author":"Weisenberger","year":"2022","journal-title":"Adv Exp Med Biol"},{"key":"R21-20260922","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1002\/ctm2.498","article-title":"An epigenomic landscape of cervical intraepithelial neoplasia and cervical cancer using single-base resolution methylome and hydroxymethylome.","volume":"11","author":"Han","year":"2021","journal-title":"Clin Transl Med"},{"key":"R22-20260922","doi-asserted-by":"crossref","first-page":"3000605211018443","DOI":"10.1177\/03000605211018443","article-title":"An 8-gene DNA methylation signature predicts the recurrence risk of cervical cancer.","volume":"49","author":"Ma","year":"2021","journal-title":"J Int Med Res"},{"key":"R23-20260922","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00404-018-4796-3","article-title":"A prospective study on the predictive value of DNA methylation in cervical intraepithelial neoplasia prognosis.","volume":"298","author":"Guo","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"R24-20260922","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.7314\/APJCP.2015.16.14.5843","article-title":"Value of PAX1 methylation analysis by MS-HRM in the triage of atypical squamous cells of undetermined significance.","volume":"16","author":"Li","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"R25-20260922","doi-asserted-by":"crossref","first-page":"44373","DOI":"10.18632\/oncotarget.6250","article-title":"JAM3 methylation status as a biomarker for diagnosis of preneoplastic and neoplastic lesions of the cervix.","volume":"6","author":"Yin","year":"2015","journal-title":"Oncotarget"},{"key":"R26-20260922","doi-asserted-by":"crossref","first-page":"A408","DOI":"10.1136\/ijgc-2022-ESGO.875","article-title":"2022-RA-902-ESGO 2005; Novel methylated genes as a second triage step after hrHPV testing to improve colposcopy referral in HPV infected women with cervical lesions (cancer).","volume":"32","author":"Li","year":"2022","journal-title":"Int J Gynecol Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050757","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:04:07Z","timestamp":1790100247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":25,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050757","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"2025-10-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}